Rauvolfia vomitoria is the West African serpentwood whose root and bark contain reserpine — the first modern antihypertensive drug, isolated in 1952. Before Western medicine named it, Yoruba and Congolese healers were using this plant to treat what we now call hypertension and psychosis. The pharmaceutical industry extracted the compound, synthesized it, patented it, and sold it back — the ancestral knowledge was never credited.
Its primary Black American value is historical and pharmacological literacy: knowing that the hypertension drug prescribed to Black grandfathers in 1965 came from a West African plant root is an act of reclamation.
Reserpine depletes central and peripheral catecholamines (norepinephrine, dopamine, serotonin) by blocking the VMAT2 transporter — producing sustained antihypertensive and sedating effects. The FDA approved reserpine as a hypertension drug in 1955. The mechanism is particularly relevant to Black American hypertension driven by sympathetic hyperactivation from chronic racial stress (Weathering Hypothesis) — reserpine directly addresses catecholamine excess. Ajmaline demonstrates Class IA antiarrhythmic activity. CNS monoamine depletion causes depression at high doses — historically causing reserpine to fall out of pharmaceutical favor despite efficacy. Ancestral use was at sub-pharmaceutical doses as a tonic, not an acute drug.
CAUTION — professional herbalist guidance required. This entry serves pharmacological literacy more than self-treatment. Do not self-prepare without knowledge of source, dose, and current medication list.
Free, no account needed to ask.